SEC Form 4 · accession 0000905536-17-000002
Adhera Therapeutics, Inc. · ATRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Isaac Blech
Director
Period of report
Nov 22, 2017
Accepted (ET)
Nov 27, 2017 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000737207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $1.80 | Nov 22, 2017 | A | 473,457 | A | — | Nov 22, 2017 | Common Stock | 473,457 | 473,457 | D |
Explanation of responses
- F1Security granted on November 22, 2017 under the Issuer's 2014 Long-Term Incentive Plan as an initial one-time grant to the Reporting Person in connection with his appointment to the Issuer's Board of Directors on November 22, 2017.
- F2The option shall vest in twenty (20) equal (or as nearly equal as possible) quarterly installments beginning December 31, 2017.